PAOLETTI, ANNA MARIA
 Distribuzione geografica
Continente #
EU - Europa 230.238
NA - Nord America 14.472
AS - Asia 2.317
SA - Sud America 45
Continente sconosciuto - Info sul continente non disponibili 31
OC - Oceania 20
AF - Africa 13
Totale 247.136
Nazione #
IT - Italia 224.313
US - Stati Uniti d'America 14.338
UA - Ucraina 2.139
CN - Cina 1.618
SE - Svezia 1.263
DE - Germania 1.102
FI - Finlandia 518
SG - Singapore 504
GB - Regno Unito 403
FR - Francia 205
RU - Federazione Russa 138
CA - Canada 119
IN - India 64
VN - Vietnam 37
BR - Brasile 31
EU - Europa 31
NL - Olanda 31
KR - Corea 29
BE - Belgio 20
AU - Australia 16
RO - Romania 15
HK - Hong Kong 12
CH - Svizzera 11
ES - Italia 10
MX - Messico 10
IE - Irlanda 9
PL - Polonia 9
CZ - Repubblica Ceca 8
JP - Giappone 8
TR - Turchia 8
IL - Israele 7
LT - Lituania 7
MU - Mauritius 7
NO - Norvegia 6
AL - Albania 5
CL - Cile 5
IR - Iran 5
PH - Filippine 5
BG - Bulgaria 4
EC - Ecuador 4
NZ - Nuova Zelanda 4
AT - Austria 3
HR - Croazia 3
ID - Indonesia 3
MD - Moldavia 3
PT - Portogallo 3
TW - Taiwan 3
BD - Bangladesh 2
CO - Colombia 2
CR - Costa Rica 2
DK - Danimarca 2
GR - Grecia 2
MA - Marocco 2
MY - Malesia 2
NG - Nigeria 2
PE - Perù 2
PK - Pakistan 2
RS - Serbia 2
SV - El Salvador 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
GE - Georgia 1
HN - Honduras 1
IS - Islanda 1
JO - Giordania 1
KZ - Kazakistan 1
ME - Montenegro 1
OM - Oman 1
SA - Arabia Saudita 1
SC - Seychelles 1
SI - Slovenia 1
ZA - Sudafrica 1
Totale 247.136
Città #
Cagliari 217.900
Uta 4.893
Fairfield 1.714
Woodbridge 1.241
Chandler 1.196
Jacksonville 1.150
Boardman 1.046
Ashburn 978
Wilmington 886
Ann Arbor 858
Houston 767
Seattle 714
Nyköping 690
Cambridge 568
Dearborn 387
Nanjing 370
Boston 264
Singapore 237
Helsinki 201
Beijing 194
Santa Clara 166
Milan 136
Shenyang 113
San Diego 111
Nanchang 104
Shanghai 94
Toronto 93
Tianjin 77
Hebei 76
Jiaxing 74
Redwood City 74
Changsha 73
Guangzhou 73
Los Angeles 65
Mountain View 62
Verona 58
Jinan 52
Norwalk 51
Orange 51
Rome 49
New York 46
Sassari 45
Washington 44
London 36
Dong Ket 34
Ningbo 33
Auburn Hills 32
Zhengzhou 28
Hefei 26
Pune 26
Kunming 21
Redmond 21
Taizhou 21
Saint Petersburg 20
Brussels 19
Columbus 18
Molise 17
Falls Church 16
Borås 15
Munich 14
San Mateo 14
Treviso 14
Hangzhou 13
Padova 13
Millbury 12
Indiana 11
Augusta 10
Chicago 9
Mumbai 9
Seoul 9
Tappahannock 9
Walnut 9
Wuhan 9
Kilburn 8
Palermo 8
Phoenix 8
Rockville 8
Torino 8
Dublin 7
Edinburgh 7
Frankfurt am Main 7
Hong Kong 7
San Germano Vercellese 7
Amsterdam 6
Arlington 6
Atlanta 6
Bern 6
Carbonia 6
Detroit 6
Fuzhou 6
Gießen 6
Jinhua 6
Messina 6
Ottawa 6
Paris 6
Santa Rosa 6
Settimo Torinese 6
Sydney 6
Yellow Springs 6
Bologna 5
Totale 238.755
Nome #
Long-acting reversible contraception (LARC) with the intrauterine system with levonorgestrel (6 mcg/d): observational study on the acceptability, quality of life, and sexuality in Italian women 3.945
Overview of elagolix for the treatment of endometriosis 3.421
Urinary metabolomics of pregnant women at term: a combined GC/MS and NMR approach 3.305
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: a prospective one-year evaluation 3.297
Systemic therapy for the treatment of endometrial cancer 2.981
Vaginosi batterica: efficacia di un trattamento locale con un gel vaginale a base di una frazione batterica derivata da Propionibacterium acnes 2.943
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 2.890
The stimulation of the vaginal immune system with short-term administration of a vaginal gel containing fraction of Propionibacterium acnes, hyaluronic acid and polycarbophil is efficacious in vaginal infections dependent on disorders in the vaginal ecosystem 2.858
Olfactory performance in relation to sex and hormonal profile in humans 2.825
Repeated two cycles of ulipristal acetate treatment improve the quality of life in premenopausal women with heavy menstrual bleeding dependent on uterine myomas, without impairment of bone health 2.806
Body composition and psychological improvement in healthy premenopausal women assuming the oral contraceptive containing micronized estradiol (E2) and nomegestrol acetate (NOMAC) 2.642
Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: A case report and literature review 2.636
Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis: a review of the literature 2.599
Studio epidemiologico sull’osteoporosi postmenopausale 2.514
Vilaprisan for treating uterine fibroids 2.461
Dismenorrea e endometriosi: una innovativa alternativa alla terapia farmacologica nel controllo del dolore 2.407
Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy 2.363
Changes of olfactory sensitivity related to sex and hormonal profile in humans 2.287
Clinical utility of elagolix as an oral treatment for women with uterine fibroids: A short report on the emerging efficacy data 2.261
Placental biomarkers 2.248
Studio osservazionale sul contraccettivo ormonale contenente estradiolo valerato e dienogest in formulazione quadrifasica: accettabilità, effetto favorevole sulla composizione corporea e sullo stato psicologico. 2.159
“CG Fem, PI 82, Vitamina E” per la terapia della menopausa: quali vantaggi per la sintomatologia neurovegetativa peri-post menopausale 2.127
Placental growth factor and preterm delivery 2.087
Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment 1.990
Studio osservazionale sul contraccettivo ormonale a base di E2 1,5 mg/NOMAC 2,5 mg in formulazione monofasica 1.965
Resistenza all’insulina nella PCOS e trattamento con inositolo e acido alfa-lipoico 1.958
Risultati di uno studio pilota sull’efficacia del palmitoiletanolamide + transpolidatina in donne con endometriosi 1.952
Maternal perinatal depression, anxiety, fear of birth, and perception of infants’ negative affectivity at three months 1.874
Contraception in chronic kidney disease: a best practice position statement by the kidney and pregnancy group of the Italian Society of Nephrology 1.859
STUDIO OSSERVAZIONALE SUL CONTRACCETTIVO ORMONALE A BASE DI ESTRADIOLO (E2) 1.5 MG/NOMEGESTROLO (NOMAC) 2.5 MG IN FORMULAZIONE MONOFASICA: ACCETTABILITA', EFFETTO FAVOREVOLE SULLA COMPOSIZIONE CORPOREA E SUI PARAMETRI ANTROPOMETRICI 1.846
Ultrasonographic soft markers for detection of rectosigmoid deep endometriosis 1.843
Screening e diagnosi del Diabete Gestazionale in Sardegna: risultati a confronto. 1.825
SARCOPENIA: DIAGNOSI E PROSPETTIVE TERAPEUTICHE 1.821
Modificazioni dell’umore e del comportamento nel puerperio: quali fattori di rischio? 1.813
Il bi-test: solo screening di cromosomopatie fetali? 1.801
Monurelle Biogel® vaginal gel in the treatment of vaginal dryness in postmenopausal women 1.739
Menopause and hormone replacement therapy: the 2017 Recommendations of the Italian Menopause Society 1.732
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 1.720
Adherence with ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen supported by the use of a digital tablet dispenser with or without acoustic alarm: an open-label, randomized, multicenter study 1.703
Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control report 1.686
Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 mu g of ethinyl estradiol 1.677
Successful laparoscopic management of a giant ovarian cyst 1.660
Fattore di Crescita Placentare (PlGF): correlazioni con la funzione placentare 1.651
Modificazione dell'umore in gravidanza e nel post-partum: ruolo degli integratori 1.650
Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study 1.634
Diagnosi isteroscopica del tumore endometriale: nostra esperienza 1.614
Changes in GABAA receptor gamma2 subunit gene expression induced by long-term administration of oral contraceptives in rats 1.599
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group 1.596
CARATTERISTICHE DELLA "MESTRUAZIONE", DELLA PRESSIONE ARTERIOSA E DEI SINTOMI PSICOLOGICI IN CORSO DI SEI CICLI DI TRATTAMENTO CON IL CONTRACCETTIVO ORMONALE A BASE DI E2 1.5 MG/NOMAC 2.5 MG 1.535
Confronto tra diagnosi isteroscopica e istologica delle patologie endometriali maligne, nostra esperienza 1.516
Contraception with estradiol valerate and dienogest: adherence to the method 1.496
Large twisted ovarian fibroma associated with Meigs' syndrome, abdominal pain and severe anemia treated by laparoscopic surgery 1.493
Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABA-A receptor agonist activity. 1.484
STUDIO OSSERVAZIONALE SUL CONTRACCETTIVO ORMONALE CONTENENTE ESTRADIOLO VALERATO E DIENOGEST IN FORMULAZIONE QUADRIFASICA: ACCETTABILITA', EFFETTO FAVOREVOLE SULLA COMPOSIZIONE CORPOREA E SULLO STATO PSICOLOGICO 1.469
Osteoporosis's Menopausal Epidemiological Risk Observation (O.M.E.R.O.) study 1.448
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel 1.405
LE ALTERAZIONI DELLA FASE OVULATORIA 1.395
Non-hormonal strategies for managing menopausal symptoms in cancer survivors: an update 1.367
Macro-regional variation in attitudes toward and experiences of vulvar and vaginal atrophy among Italian post-menopausal women: a post hoc analysis of REVIVE survey data 1.360
Placental growth factor and placental perfusion 1.322
Low androgenization index in elderly women and elderly men with Alzheimer's disease 1.311
Efficacy of intravenous tramadol treatment for reducing pain during office diagnostic hysteroscopy 1.305
INDICAZIONE AL PARTO CESAREO PRESSO LA CLINICA OSTETRICA E GINECOLOGICA DI CAGLIARI: SU QUALI POSSIAMO RIDURRE IL RICORSO AL PARTO CESAREO? 1.297
Relevant changes in nephrogenesis in Down syndrome 1.293
Soy isoflavones, inulin, calcium, and vitamin D3 in post-menopausal hot flushes: an observational study 1.281
The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study 1.263
Evidence that in healthy young women, a six-cycle treatment with oral contraceptive containing 30 mcg of ethinylestradiol plus 2 mg of chlormadinone acetate reduces fat mass 1.232
Pattern of bone markers during pregnancy and their changes after delivery. 1.229
Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 mu g of ethinyl estradiol: observational study in young postadolescent women 1.224
Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women 1.213
ANALGESIA EPIDURALE E INCIDENZA DI TAGLIO CESAREO. 1.201
Placental massive perivillous fibrin deposition after a previous uncomplicated term pregnancy: report of two cases. 1.187
EZIOPATOGENESI DEI MIOMI UTERINI 1.181
B-mode and Power Doppler Ultrasound in Adnexsal Masses 1.152
Observational study on the efficacy of tibolone in counteracting early carotid atherosclerotic lesions in postmenopausal women 1.126
The effect of vulvovaginal atrophy on women’s quality of life from an Italian cohort of the EVES study 1.117
The treatment of polycystic ovary syndrome 1.113
Correlazioni tra composizione corporea ed età 1.096
null 1.083
The impact of COVID-19 lockdown on admission to gynecological emergency departments: Results from a multicenter Italian study 1.046
Raloxifene does not modify insulin sensitivity and glucose metabolism in postmenopausal women 1.038
The 12-month treatment with the oral contraceptive formulation containing dienogest (DNG) and estradiol valerate (E2V) shows beneficial effects on psychological symptoms: results from a prospective comparative study with a formulation containing ethinyl estradiol (EE) and drospirenone (DRSP) 1.024
Reflections and recommendations on the COVID-19 pandemic: Should hormone therapy be discontinued? 1.014
La scelta razionale: terapia ormonale a basso dosaggio 1.007
Observational study on the efficacy of the supplementation with a preparation with several minerals amd vitamins in improving mood and behaviour of healty puerperal women 988
Contraception during Coronavirus-Covid 19 pandemia. Recommendations of the Board of the Italian Society of Contraception 968
The Role of biochemical screening at 11-14 weeks of gestation as predictor of both trisomy 21 and adverse pregnancy outcomes 935
CORRELAZIONI PSICO-NEUROENDOCRINE IN GRAVIDANZA. 932
Individualizing surgery for the patient with endometriosis 931
FATTORI ORMONALI NELLA DEPRESSIONE POSTPARTUM 919
The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome 902
Metabolomic approach to diagnosis of labour 902
Endocrine and metabolic aspects in obese and lean young PCOS 891
Non-enhanced Transvaginal Ultrasonography 858
Test di screenibg combinato del primo trimestre ed outcome della gravidanza 852
LA PREVALENZA DEL DIABETE GESTAZIONALE IN SARDEGNA: RISULTATI CON DIVERSE PROCEDURE DI SCREENING E DIAGNOSI 846
Alcohol and pregnancy 840
null 814
Efficacy and safety of oral and transdermal hormonal replacement treatment containing levonorgestrel. 811
Prevalence of deep endometriosis in patients of a second level ultrasound laboratory and tissue US characterization of nodules using VOCAL 806
Totale 165.788
Categoria #
all - tutte 331.337
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 331.337


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022.284 0 0 0 0 0 9.825 6.398 1.560 973 750 1.227 1.551
2020/202159.020 2.096 2.048 2.513 14.917 12.682 7.427 6.440 3.458 1.115 2.485 2.495 1.344
2021/202213.719 1.339 1.099 581 1.097 1.273 1.049 1.223 678 1.119 1.172 1.516 1.573
2022/202319.530 2.034 2.185 2.190 1.436 1.536 1.748 773 3.042 1.287 981 1.548 770
2023/202425.933 1.565 1.429 1.192 1.953 2.807 4.246 4.430 1.463 1.198 1.745 2.055 1.850
2024/202525.817 4.382 6.941 5.441 4.813 2.487 1.753 0 0 0 0 0 0
Totale 247.580